Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer

This webinar from the Association for Molecular Pathology (AMP) will review the recently published expert consensus recommendations for clinical molecular laboratories for the detection of homologous recombination deficiency (HRD) in cancer, developed by the AMP Clinical Practice Committee’s PARP HRD Working Group. The recommendations encompass pre-analytical, analytical, and post-analytical factors that play a role in genomic instability and/or HRD analytical validation and reporting.

To register, visit: https://register.gotowebinar.com/register/1059037957915706199